Users of this system, can login to view this document.


Enter the following information to request a copy of the document from the responsible person.

Interim Guidance for the use of Tocilizumab in the Management of Patients who have Severe COVID-19 with Suspected Hyperinflammation [v5.0]

This email address is used for sending the document.